Cargando…
Cas9 immunity creates challenges for CRISPR gene editing therapies
Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 is a genome-editing technology(1,2) that utilizes archaeal and bacterial Cas9 nucleases to introduce double-stranded breaks in DNA at targeted sites. These breaks can be used to remove, replace, or add pieces of DNA. While not t...
Autores principales: | Crudele, Julie M., Chamberlain, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115392/ https://www.ncbi.nlm.nih.gov/pubmed/30158648 http://dx.doi.org/10.1038/s41467-018-05843-9 |
Ejemplares similares
-
Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma Studies
por: Kang, Xianhui, et al.
Publicado: (2023) -
Knocking out consumer concerns and regulator’s rules: efficient use of CRISPR/Cas ribonucleoprotein complexes for genome editing in cereals
por: Wolter, Felix, et al.
Publicado: (2017) -
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
por: Li, Ang, et al.
Publicado: (2020) -
Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021) -
CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)